最新观点
Insights From Our Experts
Articles
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Mike Ryan, General Manager, Europe, at EVERSANA, connected in a conversation with PharmaShots before Reuters Pharma 2025 in Barcelona, which ran 9-11 April 2025. Mike’s discussion focused on the history of EVERSANA and how the company…
CASE STUDY: Transforming Clinical Trials with EVERSANA
Posted by
on 4 月 4, 20254/4/25
Modernizing Clinical Trials to Accelerate Access Clinical trials are essential for bringing life-changing therapies to market, yet traditional models often present significant barriers for both participants and trial sites. A leading pharmaceutical manufacturer partnered with EVERSANA…
Generic Substitution in Southeast Asia and Emerging Markets: Key Insights for Strategic Decision-Making
Are you curious about the evolving landscape of generic substitution in Southeast Asia and other emerging markets? Our latest white paper, Generic Substitution in Southeast Asia and Emerging Markets: Key Insights for Strategic Decision-Making, delves into the…
Maximizing Sales with AI: A Strategic Roadmap for Success
Artificial intelligence (AI) is transforming the sales landscape, offering innovative ways to boost efficiency, enhance decision-making and drive revenue growth. With AI adoption in sales ranking among the top three functions across industries, organizations must leverage…
Rare Disease Care in India: A Path to Positive Impact
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Navigating the complexities of bringing new drug therapies to market in Europe is a formidable challenge, especially with the diverse and fragmented reimbursement landscape across the EU’s 27 member states. In this insightful article published in…
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
The EU Health Technology Assessment Regulation (HTAR), effective from January 12, 2025, aims to harmonize the evaluation of health technologies across member states to enhance patient access to innovative treatments. In this latest article from Pamela…
Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficiency
Posted by Maneesh Gupta , Matt Doyle , Nolan Kleinhenz , Andrew Therrien, PhD , Emily Bradshaw on 2 月 21, 20252/21/25
Discover the transformative power of EVERSANA’s innovative commercialization model in our latest white paper. This essential guide is perfect for pharmaceutical companies, particularly first-time launchers, aiming to navigate the complexities of product commercialization. It addresses the…
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services
Navigating the healthcare system can be enormously challenging for patients, who often face numerous obstacles that hinder their access to quality care. Common barriers include financial constraints, long wait times, socio-economic disparities, fragmented care coordination, among…
Strategic Market Access: Innovative Branding Strategies in Emerging Markets
Authors: Amardeep Udeshi, SVP, EVERSANA APAC; Ankit Kulshrestha, Senior Principal, EVERSANA APAC; Nishit Patadia, Engagement Manager, EVERSANA APAC In the dynamic landscape of the pharmaceutical industry, traditional linear market access approaches are no longer sufficient. This…